# Enhanced Antitumor Activity of Korean Black Soybean Cultivar ‘Soman’ by Targeting STAT-Mediated Aerobic Glycolysis

**Authors:** Su Hwan Park, Jeong Hyun Seo, Min Young Kim, Hye Jin Yun, Beom Kyu Kang, Jun Hoi Kim, Su Vin Heo, Yeong Hoon Lee, Hye Rang Park, Man Soo Choi, Jong-Ho Lee

PMC · DOI: 10.3390/antiox14020228 · Antioxidants · 2025-02-18

## TL;DR

The Korean black soybean 'Soman' shows stronger antitumor effects than other soybean varieties by targeting cancer cell metabolism.

## Contribution

Soman's antitumor activity is linked to its suppression of STAT-mediated aerobic glycolysis in cancer cells.

## Key findings

- Soman inhibits cancer cell proliferation more effectively than Seoritae.
- Soman reduces glycolytic enzyme activity and ATP production in cancer cells.
- Soman suppresses tumor growth in a murine melanoma model by inhibiting STAT phosphorylation.

## Abstract

Black soybeans have numerous health benefits owing to their high polyphenolic content, antioxidant activity, and antitumor effects. We previously reported that the Korean black soybean cultivar ‘Soman’ possesses higher anthocyanin and isoflavone contents and superior antioxidant potential than other Korean black soybean cultivars and landraces (Seoritae) do. Here, we investigated and compared the antitumor effects of Soman and Seoritae and aimed to elucidate the possible mechanisms of action. Soman inhibited cancer cell proliferation and was more potent than Seoritae. Mechanistically, Soman inhibited the phosphorylation of the signal transducer and activator of transcription (STAT1, 3, and 5) in a reactive oxygen species (ROS)-independent manner, subsequently decreasing glycolytic enzyme expression and the activities of pyruvate kinase and lactate dehydrogenase. Thus, Soman suppressed glucose uptake, lactate production, and ATP production in cancer cells. Additionally, it inhibited tumor growth in a B16F10 murine melanoma syngeneic model, accompanied by reduced STAT1 phosphorylation and decreased proliferation in Soman-treated mice, more potently than observed in Seoritae-treated mice. These findings showed that Soman exerted superior antitumor activities by suppressing STAT-mediated aerobic glycolysis and proliferation. Overall, our findings demonstrate the potent, tumor-suppressive role of Soman in human cancer and uncover a novel molecular mechanism for its therapeutic effects in cancer treatment.

## Linked entities

- **Genes:** STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772], STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774], STAT5A (signal transducer and activator of transcription 5A) [NCBI Gene 6776]
- **Diseases:** cancer (MONDO:0004992)

## Full-text entities

- **Genes:** Stat1 (signal transducer and activator of transcription 1) [NCBI Gene 20846] {aka 2010005J02Rik}
- **Diseases:** cancer (MESH:D009369)
- **Chemicals:** anthocyanin (MESH:D000872), isoflavone (MESH:D007529), ROS (MESH:D017382), glucose (MESH:D005947), Soman (MESH:D012999), Seoritae (-), lactate (MESH:D019344), ATP (MESH:D000255)
- **Species:** Glycine max (soybean, species) [taxon 3847], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** B16F10 — Mus musculus (Mouse), Mouse melanoma, Cancer cell line (CVCL_0159)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11852074/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11852074/full.md

## References

65 references — full list in the complete paper: https://tomesphere.com/paper/PMC11852074/full.md

---
Source: https://tomesphere.com/paper/PMC11852074